Derniers ajouts - PDR Vitreous hemorrhage and non-perfusion 36-year-old woman There has been blurred vision in the left eye for about 2.5 weeks. She had a similar episode a few years ago. She has been seeing another retina specialist who left the area. She had inadequate PRP laser
PMHx: Type 1 DM diagnosed at age 8.
Systemic Meds: Tresiba qday. Lisinopril qday. Estradiol qday. Spirolactone bid. Humalog 300 UNT per 3 ML Pen
VA OD: 20/25, OS: 20/80
IOP 10 OU
SLE: 1+ NS OU
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 2 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 1 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|

PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vu 0 fois36 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/8017 Août 2026
|
|
|
|
|
|
|
36-year-old woman There has been blurred vision in the left eye for about 2.5 weeks. She had a similar episode a few years ago. She has been seeing another retina specialist who left the area. She had inadequate PRP laser
PMHx: Type 1 DM diagnosed at age 8.
Systemic Meds: Tresiba qday. Lisinopril qday. Estradiol qday. Spirolactone bid. Humalog 300 UNT per 3 ML Pen
VA OD: 20/25, OS: 20/80
IOP 10 OU
SLE: 1+ NS OU